Management Advisory Council
The BHCRI Management Advisory Council is composed of:
3 members from discovery/experimental research
3 members from clinical/translational research
2 members from population health research
2 members from behavioural research (to be interpreted broadly)
2 members from locally active supporting organizations
2 members from nationally active supporting organizations
4 members from the lay/business community
with significant representation of all four Atlantic Provinces
Members of the BHCRI Management Advisory Council:
- Dr. Stephen Lewis, Chair, Assistant Scientific Director, Atlantic Cancer Research Institute, Moncton, NB
Dr. Stephen M. Lewis received his Ph.D. from Dalhousie University in 2004, where he studied the molecular mechanisms of vesicle trafficking in the budding yeast Saccharomyces cerevisiae. From 2004 until 2007, he pursued postdoctoral training in the molecular biology of translational control at the Apoptosis Research Centre, located at the University of Ottawa. Dr. Lewis joined the Atlantic Cancer Research Institute in 2008 as a Research Scientist and has been the Assistant Scientific Director since 2013. At ACRI he oversees projects on the use of extracellular vesicles for cancer detection and therapeutics, as well as projects focused on the identification of novel therapeutic targets for cancer. Dr. Lewis’s independent research program is investigating how deregulated protein synthesis contributes to the development and progression of cancer, with a particular emphasis on metastatic breast cancer.
- Ms. Erika Nicholson, Vice-Chair; Director, Screening and Early Detection, Canadian Partnership Against Cancer, Halifax, NS
Erika is the Director, Screening and Early Detection with the Canadian Partnership Against Cancer – an independent organization funded by the federal government to accelerate action on cancer control for all Canadians. Prior to joining the Partnership, Erika was Senior Director for the Nova Scotia Cancer Care Program, Nova Scotia Health Authority, and was responsible for the overall transformation and management of cancer care services in the province. She has more than a decade of strategic leadership experience in cancer control in Nova Scotia – establishing herself as a driver of system change built on a solid foundation of stakeholder engagement and moving evidence into practice. Erika holds a Bachelor of Science in Nutritional Science and a Masters of Health Science in Community Health, both from the University of Toronto.
- Ms. Joanne Bath, CEO, Dalhousie Medical Research Foundation, Halifax, NS
- Ms. Leah Carr, Acting Co-CEO / Director, Research Programs and Human Development, New Brunswick Health Research Foundation, Fredericton, NB
- Dr. Sheila Drover, Associate Professor of Immunology, BioMedical Sciences, Memorial University, St. John's, NL
- Dr. Conrad Fernandez, Pediatric Hematologist/Oncologist, Departments of Pediatrics and Bioethics, IWK Health Centre, Halifax, NS
Dr. Conrad Fernandez is a professor and head of the Division of Pediatric Hematology/Oncology in the Department of Pediatrics, IWK Health Centre, Dalhousie University. He is cross-appointed in the Departments of Bioethics. He is vice-Chair of the Children’s Oncology Group (COG) Bioethics committee and co-Chair of the newly established COG Return of Research Results committee. He has an active research program in the return of research results to participants. He is also a member of the COG renal tumors steering committee and conducts clinical trials in childhood kidney cancer.
- Dr. Scott Grandy, Associate Professor, Kinesiology, School of Health and Human Performance, Dalhousie University, Halifax, NS
- Ms. Heather Hogan, Patient Partner and Lung Cancer Advocate, NB
Heather Hogan (BA, Bed, Med) is a retired teacher and school administrator from Woodstock, New Brunswick. Having been diagnosed with Stage 3a Adenocarcinoma lung cancer in 2012 (with a 15% chance of surviving five years), Heather knows first hand the importance of research. Heather is currently a Patient Partner with the Maritime SPOR Support Unit’s Scientific Leadership Committee and a Peer Support member with Lung Cancer Canada as part of their Programs Committee.“I believe in the advancement of all cancer research as well as promoting patient engagement in research. I have seen the benefits of collaboration between stakeholders and I have also learned that research done in Atlantic Canada can compete both nationally and internationally.”
- Dr. Sara Kirk, Scientific Director, Healthy Populations Institute, Dalhousie University, Halifax, NS
Dr. Kirk is a professor of health promotion in the School of Health and Human Performance, and the Scientific Director of the Healthy Populations Institute. She holds cross-appointments with Community Health and Epidemiology, is an adjunct professor at Mount Saint Vincent University, in the Department of Applied Human Nutrition, and honorary senior scientist with the Beatrice Hunter Cancer Research Institute. Her research seeks to understand how we can create supportive environments for chronic disease prevention. She applies a ‘socio-ecological’ approach that considers how individual behaviour is influenced by other broader factors, such as income, education and societal norms.
- Ms. Susan Mullin, President and CEO, QEII Foundation, Halifax, NS
Susan Mullin returned home to Nova Scotia in June 2020 to join the QEII Health Sciences Centre Foundation as President & Chief Executive Officer. Susan graduated from Mount Allison University and has dedicated her 30-year career to leading successful capital campaigns, major gift and annual giving programs in the health and higher education sectors. She previously served in senior executive roles in Ontario with organizations including Southlake Foundation, CAMH Foundation and York University. In addition to her professional experience, Susan is an active and committed volunteer having served as chair of the Association of Fundraising Professionals (AFP) Greater Toronto Chapter; chair of AFP Canada’s Government Relations Committee; and, as a member of the board of Community One Foundation. She currently serves as a member of the board of directors of Casey House Hospital in Toronto. Susan received the Outstanding Fundraising Professional Association of Fundraising Professionals (AFP), Greater Toronto Chapter in 2010.
- Dr. Anthony Reiman, Canadian Cancer Society Research Chair, University of New Brunswick; Medical Oncologist, Saint John Regional Hospital; Assistant Dean, Research, Dalhousie Medicine New Brunswick
Dr. Reiman is a medical oncologist at the Saint John Regional Hospital, where he provides front line cancer care including diagnosis, systemic therapy and opportunities for patients to participate in research protocols. He is the Canadian Cancer Society Research Chair at the University of New Brunswick, with a focus on novel therapies and biomarkers for multiple myeloma, lymphoma and lung cancer. As Professor of Medicine and Assistant Dean, Research for the Dalhousie Medicine New Brunswick program, Dr. Reiman has helped to build and maintain a new research program in New Brunswick including cardiovascular research, occupational medicine and oncology and the provision of research opportunities to medical students, undergraduates, residents and postdoctoral fellows. Dr. Reiman serves on the board of directors of the New Brunswick Health Research Foundation and the scientific advisory boards of Myeloma Canada and Lymphoma Canada. He is on several committees of the NCIC Clinical Trials Group and is a member of the US NCI Myeloma Steering Committee and the International Myeloma Working Group. Dr. Reiman has published over 180 peer reviewed cancer research manuscripts and presentations.
- Dr. John Thoms, Radiation Oncologist, Dr. H. Bliss Murphy Cancer Centre, St. John's, NL
- Dr. Sandra Turcotte, Professor, Chemistry and Biochemistry, Universite de Moncton, NB
BHCRI Senior Scientist Dr Sandra Turcotte, is an Assistant Professor at the Université de Moncton and researcher in residence at the Atlantic Cancer Research Institute. She completed her PhD in Biochemistry at the Université du Québec à Montréal and Post-doctoral Fellowships at Stanford University in California and at the CRCHUM in Montreal.
Her research focus is on developing new targeted therapy for kidney cancer. Her studies identify a small molecule that kills renal cancer cells and spare normal cells. Her laboratory uses a variety of methods in cell and molecular biology to study the role of autophagy in kidney cancer. Dr Turcotte holds a Canadian Cancer Society Research Chair in New Brunswick and is a KRESCENT New Investigator awardee.
- Dr. Robin Urquhart, Assistant Professor, Department of Surgery, Dalhousie University, Halifax, NS
Dr. Robin Urquhart is an Assistant Professor and Ramia Scientist in the Department of Surgery at Dalhousie University, with cross-appointments in the Department of Community Health and Epidemiology and Division of Medical Education. She is also an Affiliate Scientist at the Nova Scotia Health Authority. Her research relates to understanding how scientific evidence moves into clinical practice and policy for persons diagnosed with cancer, and which strategies optimize its implementation, scale-up, and sustained use. The goal of her research is to increase the use of scientific evidence across settings so that important discoveries reach more people, more quickly, and in a more lasting way. Robin’s contributions to health research and health care have been recognized by numerous awards, including the 2014 Discovery Award for Science and Technology (Emerging Professional category).